Search

Search Constraints

You searched for: Author/Creator Zhu, Mengjia

Search Results

4. IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma. (28th June 2022)